Sibutramine
A Study to Examine the Efficacy and Safety of Meridia® (Sibutramine Hydrochloride) in Binge-Eating Disorder
Abbott · Phase 3 · Completed · Enrollment 304
| Arm | Population | Dose | Weeks | Estimand | Weight change |
|---|---|---|---|---|---|
| Registry arm not named | Obesity or overweight | n/r | n/r | n/r | n/r |